Kielian M, Klimjack M R, Ghosh S, Duffus W A
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
J Cell Biol. 1996 Aug;134(4):863-72. doi: 10.1083/jcb.134.4.863.
Semliki Forest virus (SFV) infects cells by an acid-dependent membrane fusion reaction catalyzed by the virus spike protein, a complex containing E1 and E2 transmembrane subunits. E1 carries the putative virus fusion peptide, and mutations in this domain of the spike protein were previously shown to shift the pH threshold of cell-cell fusion (G91A), or block cell-cell fusion (G91D). We have used an SFV infectious clone to characterize virus particles containing these mutations. In keeping with the previous spike protein results, G91A virus showed limited secondary infection and an acid-shifted fusion threshold, while G91D virus was noninfectious and inactive in both cell-cell and virus-liposome fusion assays. During the low pH- induced SFV fusion reaction, the E1 subunit exposes new epitopes for monoclonal antibody (mAb) binding and forms an SDS-resistant homotrimer, the virus associates hydrophobically with the target membrane, and fusion of the virus and target membranes occurs. After low pH treatment, G91A spike proteins were shown to bind conformation-specific mAbs, associate with target liposome membranes, and form the E1 homotrimer. However, both G91A membrane association and homotrimer formation had an acid-shifted pH threshold and reduced efficiency compared to wt virus. In contrast, studies of the fusion-defective G91D mutant showed that the virus efficiently reacted with low pH as assayed by mAb binding and liposome association, but was essentially inactive in homotrimer formation. These results suggest that the G91D mutant is noninfectious due to a block in a late step in membrane fusion, separate from the initial reaction to low pH and interaction with the target membrane, and involving the lack of efficient formation of the E1 homotrimer.
塞姆利基森林病毒(SFV)通过由病毒刺突蛋白催化的酸依赖性膜融合反应感染细胞,该刺突蛋白是一种包含E1和E2跨膜亚基的复合物。E1携带假定的病毒融合肽,先前已表明刺突蛋白该结构域中的突变会改变细胞间融合的pH阈值(G91A),或阻断细胞间融合(G91D)。我们使用了一种SFV感染性克隆来表征含有这些突变的病毒颗粒。与先前的刺突蛋白结果一致,G91A病毒显示出有限的二次感染和酸转移的融合阈值,而G91D病毒在细胞间和病毒-脂质体融合试验中均无感染性且无活性。在低pH诱导的SFV融合反应过程中,E1亚基暴露新的表位以供单克隆抗体(mAb)结合并形成抗SDS的同源三聚体,病毒与靶膜疏水结合,然后病毒膜与靶膜发生融合。低pH处理后,G91A刺突蛋白显示出与构象特异性mAb结合、与靶脂质体膜结合并形成E1同源三聚体。然而,与野生型病毒相比,G91A的膜结合和同源三聚体形成均具有酸转移的pH阈值且效率降低。相比之下,对融合缺陷型G91D突变体的研究表明,该病毒与低pH有效反应,如通过mAb结合和脂质体结合测定,但在同源三聚体形成方面基本无活性。这些结果表明,G91D突变体无感染性是由于膜融合后期步骤受阻所致,这与对低pH的初始反应及与靶膜的相互作用无关,且涉及E1同源三聚体缺乏有效形成。